Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of low-dose
interferon-alfa-2b plus ribavirin compared to the standard-dose of the same combination in
patients with chronic hepatitis C.